The Companion Diagnostics Market size is expected to grow at an annual average of 20% during 2021-2027. Companion diagnostics are medical devices used as in vitro diagnostic devices, which provide essential information about a drug or therapeutic product, such as whether the drug is safe and effective for a particular treatment in a patient, and to identify whether a patient is more likely. They benefit from prescription drugs and also do drug monitoring for their patients. Companion Diagnostic (CDx) is a clinical test co-developed with a therapeutic drug to screen responders and non-responders to a particular drug. It is done to identify a group of patients that can or cannot be treated with that drug. CDx helps ensure patient safety by helping doctors determine the benefits, side effects, and risks associated with taking medication.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Companion Diagnostics Market at: https://www.orionmarketreports.com/request-sample/?id=58676
The following segmentation are covered in this report:
By Product & Service
- Assay kits & Reagents
- Software & Services
By Technology
- Polymerase Chain Reaction (PCR)
- In Situ Hybridization (ISH)
- Next-Generation Sequencing (NGS)
- Immunohistochemistry (IHC)
- Others (Multiplex Assay and Cellular Imaging Technologies)
By Indication
- Cardiovascular
- Neurological Diseases
- Cancer
Company Profile
- Abbott Laboratories Molecular, Inc.
- Agilent (Dako Denmark A/S)
- ARUP Laboratories, Inc.
- BioMerieux
- Danaher Corporation (Leica Microsystems)
- Foundation Medicine, Inc.
- Myriad Genetics, Inc.
- Roche (Ventana Medical Systems, Inc)
- Thermo Fisher Scientific (Life Technologies Corporation)
- QIAGEN N.V.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Companion Diagnostics Market
- The market share of the global Companion Diagnostics Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Companion Diagnostics Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Companion Diagnostics Market
Scope of the report
The research study analyses the Companion Diagnostics Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent developments
- Market overview and growth analysis
- Import and export overview
- Volume analysis
- Current market trends and future outlook
- Market opportunistic and attractive investment segment
A full report of Companion Diagnostics Market is available at: https://www.orionmarketreports.com/companion-diagnostics-market/58676/
Geographic coverage
- North america market size and/or volume
- Latin america market size and/or volume
- Europe market size and/or volume
- Asia-pacific market size and/or volume
- Rest of the world market size and/or volume
Key Questions Answered by Companion Diagnostics Market Report
- What was the Companion Diagnostics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
- What will be the CAGR of Market during the forecast period (2021-2027)?
- Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
- Which manufacturer/vendor/players in the Companion Diagnostics Market was the market leader in 2020?
- Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
